Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 19 Breast Neoplasms 17 Advanced Solid Tumors 16 Advanced Solid Tumor 12 Carcinoma, Non-Small-Cell Lung 10 Myelodysplastic Syndromes 9 Uterine Cervical Neoplasms 6 Solid Tumor 6 Recurrence 6 Prostatic Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 6 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Ovarian Neoplasms 5 Carcinoma, Hepatocellular 5 Small Cell Lung Carcinoma 4 Myeloproliferative Disorders 4 Multiple Myeloma 4 Advanced Solid Tumour 4 Advanced Malignant Solid Tumor 4 Solid Tumors 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Biliary Tract Neoplasms 3 Advanced Lung Cancer 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2

Interventions

Oxaliplatin 13 Bevacizumab 11 Capecitabine 10 Fluorouracil 8 Blood Specimen Collection 8 Leucovorin 7 Cetuximab 7 Folfox protocol 6 pembrolizumab 5 Drug Therapy 5 trifluridine tipiracil drug combination 4 dostarlimab 4 Nivolumab 4 Irinotecan 4 HMPL-013 4 fludarabine 3 XELOX 3 Specimen Handling 3 IFL protocol 3 Cyclophosphamide 3 Biopsy 3 toripalimab 2 tislelizumab 2 tipiracil 2 regorafenib 2 pertuzumab 2 envafolimab 2 encorafenib 2 cemiplimab 2 atezolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colonic Neoplasms × Injections × Clear all

NCT05870800 2025-05-25

NICER

Baylor College of Medicine

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡